Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2472-2484

  Alamro, Mohamed ^a   Bidmos, Fadil A ^a   Chan, Hannah ^b   Oldfield, Neil J ^c   Newton, Emma ^d   Bai, Xilian ^d   Aidley, Jack ^a   Care, Rory ^b   Mattick, Claire ^b   Turner, David P J ^c   Neal, Keith R ^c   Ala'Aldeen, Dlawer A A ^c   Feavers, Ian ^b   Borrow, Ray ^d   Bayliss, Christopher D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MICROSATELLITE DNA;

ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; DISEASE CARRIER; FETA GENE; GENE EXPRESSION; GENE MUTATION; IMMUNE RESPONSE; MENINGOCOCCOSIS; NADA GENE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SERUM BACTERICIDAL ACTIVITY; SIMPLE SEQUENCE REPEAT; WESTERN BLOTTING; ADAPTIVE IMMUNITY; ANTIGENIC VARIATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTIVE IMMUNITY; ANTIBODIES, BACTERIAL; ANTIGENIC VARIATION; BLOTTING, WESTERN; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MENINGOCOCCAL INFECTIONS; MICROSATELLITE REPEATS; NEISSERIA MENINGITIDIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84900400306     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01521-14     Document Type: Article

References (49)

1. Moxon ER, Bayliss CD, Hood DW. 2007. Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu. Rev. Genet. 40:307-333. http://dx.doi.org/10.1146/annurev.genet.40.110405.090442.
2. van der Woude MW, Baumler AJ. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581-611. http://dx.doi.org/10.1128/CMR.17.3.581-611.2004.
3. Bayliss CD. 2009. Determinants of phase variation rate and the fitness implications of differing rates for bacterial pathogens and commensals. FEMS Microbiol. Rev. 33:504-520. http://dx.doi.org/10.1111/j.1574-6976.2009.00162.x.
4. Deitsch KW, Lukehart SA, Stringer JR. 2009. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7:493-503. http://dx.doi.org/10.1038/nrmicro2145.
5. Moxon ER, Rainey PB, Nowak MA, Lenski R. 1994. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol. 4:24-33. http://dx.doi.org/10.1016/S0960-9822(00)00005-1.
6. Cholon DM, Cutter D, Richardson SK, Sethi S, Murphy TF, Look DC, St Geme JW, III. 2008. Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesins. Infect. Immun. 76: 4463-4468. http://dx.doi.org/10.1128/IAI.00499-08.
7. Hobbs MM, Sparling PF, Cohen MS, Shafer WM, Deal CD, Jerse AE. 2011. Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC. Front. Microbiol. 2:123. http://dx.doi.org/10.3389/fmicb.2011.00123.
8. Woods JP, Cannon JG. 1990. Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis. Infect. Immun. 58:569-572.
9. Bayliss CD, Field D, Moxon ER. 2001. The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J. Clin. Invest. 107:657-662. http://dx.doi.org/10.1172/JCI12557.
10. Granoff DM. 2010. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50(Suppl 2):S54-S65. http://dx.doi.org/10.1086/648966.
11. Truck J, Pollard AJ. 2010. Challenges in immunization against bacterial infection in children. Early Hum. Dev. 86:695-701. http://dx.doi.org/10.1016/j.earlhumdev.2010.08.010.
12. Caugant DA, Maiden MC. 2009. Meningococcal carriage and disease-population biology and evolution. Vaccine 27(Suppl 2):B64-B70.
13. Jordens JZ, Williams JN, Jones GR, Christodoulides M, Heckels JE. 2004. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students. Infect. Immun. 72:6503-6510. http://dx.doi.org/10.1128/IAI.72.11.6503-6510.2004.
14. Goldschneider I, Gotschlich EC, Artenstein MS. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
15. Goldschneider I, Gotschlich EC, Artenstein MS. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
16. Bidmos FA, Neal KR, Oldfield NJ, Turner DP, Ala'Aldeen DA, Bayliss CD. 2011. Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort. J. Clin. Microbiol. 49:506-512. http://dx.doi.org/10.1128/JCM.01322-10.
17. Maiden MC, Stuart JM. 2002. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359:1829-1831. http://dx.doi.org/10.1016/S0140-6736(02)08679-8.
18. Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbe M, Toralta J, Kodbesse B, Ngadoua C, Coldiron M, Fermon F, Page AL, Djingarey M, Hugonnet S, Harrison O, Rebbetts L, Tekletsion Y, Watkins E, Hill D, Caugant D, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart J, Maiden M, Greenwood B. 2014. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 383:40-47. http://dx.doi.org/10.1016/S0140-6736(13)61612-8.
19. Saunders NJ, Jeffries AC, Peden JF, Hood DW, Tettelin H, Rappouli R, Moxon ER. 2000. Repeat-associated phase-variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol. Microbiol. 37:207-215. http://dx.doi.org/10.1046/j.1365-2958.2000.02000.x.
20. Virji M. 2009. Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat. Rev. Microbiol. 7:274-286. http://dx.doi.org/10.1038/nrmicro2097.
21. Perkins-Balding D, Ratliff-Griffin M, Stojiljkovic I. 2004. Iron transport systems in Neisseria meningitidis. Microbiol. Mol. Biol. Rev. 68:154-171. http://dx.doi.org/10.1128/MMBR.68.1.154-171.2004.
22. Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, Feron CM, Poolman JT, Virji M. 2011. Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol. Microbiol. 82:1129-1149. http://dx.doi.org/10.1111/j.1365-2958.2011.07876.x.
23. Hubert K, Pawlik MC, Claus H, Jarva H, Meri S, Vogel U. 2012. Opc expression, LPS immunotype switch, and pilin conversion contribute to serum resistance of unencapsulated meningococci. PLoS One 7:e45132. http://dx.doi.org/10.1371/journal.pone.0045132.
24. Rosenqvist E, Hoiby EA, Wedege E, Kusecek B, Achtman M. 1993. The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies. J. Infect. Dis. 167:1065-1073. http://dx.doi.org/10.1093/infdis/167.5.1065.
25. Tauseef I, Ali YM, Bayliss CD. 2013. Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis. Infect. Immun. 81:1374-1380. http://dx.doi.org/10.1128/IAI.01358-12.
26. Tauseef I, Harrison OB, Wooldridge KG, Feavers IM, Neal KR, Gray SJ, Kriz P, Turner DP, Ala'Aldeen DA, Maiden MC, Bayliss CD. 2011. Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence. Microbiology 157:1446-1456. http://dx.doi.org/10.1099/mic.0.046946-0.
27. Oldfield NJ, Matar S, Bidmos FA, Alamro M, Neal KR, Turner DP, Bayliss CD, Ala'aldeen DA. 2013. Prevalence and phase-variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis. PLoS One 8:e69746. http://dx.doi.org/10.1371/journal.pone.0069746.
28. De Bolle X, Bayliss CD, Field D, van de Ven T, Saunders NJ, Hood DW, Moxon ER. 2000. The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol. Microbiol. 35:211-222. http://dx.doi.org/10.1046/j.1365-2958.2000.01701.x.
29. Lucidarme J, Findlow J, Chan H, Feavers IM, Gray SJ, Kaczmarski EB, Parkhill J, Bai X, Borrow R, Bayliss CD. 2013. The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis. PLoS One 8:e76932. http://dx.doi.org/10.1371/journal.pone.0076932.
30. Gheesling LL, Carlone GM, Pais LB, Holder PF, Maslanka SE, Plikaytis BD, Achtman M, Densen P, Frasch CE, Kayhty H, Mays JP, Nencioni L, Peeters C, Phipps DC, Poolman JT, Rosenqvist E, Siber GR, Thiesen B, Tai J, Thompson CM, Vella PP, Wenger JD. 1994. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1475-1482.
31. Maslanka SE, Gheesling LL, Libutti DE, Donaldson KB, Harakeh HS, Dykes JK, Arhin FF, Devi SJ, Frasch CE, Huang JC, Kriz-Kuzemenska P, Lemmon RD, Lorange M, Peeters CC, Quataert S, Tai JY, Carlone GM, The Multilaboratory Study Group. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
32. Poolman JT, Kriz-Kuzemenska P, Ashton F, Bibb W, Dankert J, Demina A, Froholm LO, Hassan-King M, Jones DM, Lind I, Prakash K, Xujing H. 1995. Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin. Diagn. Lab. Immunol. 2:69-72.
33. Metruccio MM, Pigozzi E, Roncarati D, Berlanda Scorza F, Norais N, Hill SA, Scarlato V, Delany I. 2009. A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements. PLoS Pathog. 5:e1000710. http://dx.doi.org/10.1371/journal.ppat.1000710.
34. Tavano R, Capecchi B, Montanari P, Franzoso S, Marin O, Sztukowska M, Cecchini P, Segat D, Scarselli M, Arico B, Papini E. 2011. Mapping of the Neisseria meningitidis NadA cell-binding site: relevance of predicted α-helices in the NH2-terminal and dimeric coiled-coil regions. J. Bacteriol. 193:107-115. http://dx.doi.org/10.1128/JB.00430-10.
35. Turner DP, Marietou AG, Johnston L, Ho KK, Rogers AJ, Wooldridge KG, Ala'Aldeen DA. 2006. Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis. Infect. Immun. 74:2957-2964. http://dx.doi.org/10.1128/IAI.74.5.2957-2964.2006.
36. Virji M, Makepeace K, Peak IR, Ferguson DJ, Jennings MP, Moxon ER. 1995. Opc-and pilus-dependent interactions of meningococci with human endothelial cells; molecular mechanisms and modulation by surface polysaccharides. Mol. Microbiol. 18:741-754. http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_18040741.x.
37. Carson SD, Klebba PE, Newton SM, Sparling PF. 1999. Ferric enterobactin binding and utilization by Neisseria gonorrhoeae. J. Bacteriol. 181: 2895-2901.
38. Arenas J, Nijland R, Rodriguez FJ, Bosma TN, Tommassen J. 2013. Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the alpha-peptide of IgA protease and the autotransporter protease NalP, in initiation of biofilm formation. Mol. Microbiol. 87:254-268. http://dx.doi.org/10.1111/mmi.12097.
39. Roussel-Jazede V, Jongerius I, Bos MP, Tommassen J, van Ulsen P. 2010. NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface. Infect. Immun. 78:3083-3089. http://dx.doi.org/10.1128/IAI.01193-09.
40. Bayliss CD, Bidmos FA, Anjum A, Manchev VT, Richards RL, Grossier JP, Wooldridge KG, Ketley JM, Barrow PA, Jones MA, Tretyakov MV. 2012. Phase variable genes of Campylobacter jejuni exhibit high mutation rates and specific mutational patterns but mutability is not the major determinant of population structure during host colonization. Nucleic Acids Res. 40:5876-5889. http://dx.doi.org/10.1093/nar/gks246.
41. Bidmos FA, Bayliss CD. 2014. Genomic and global approaches to unravelling how hypermutable sequences influence bacterial pathogenesis. Pathogens 3:164-184. http://dx.doi.org/10.3390/pathogens3010164.
42. Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, Stevens J, Levin M, Ison C, Pizza M, Rappuoli R, Kroll JS. 2004. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J. Infect. Dis. 190:1488-1497. http://dx.doi.org/10.1086/424464.
43. Horton RE, Stuart J, Christensen H, Borrow R, Guthrie T, Davenport V, Finn A, Williams NA, Heyderman RS. 2005. Influence of age and carriage status on salivary IgA to Neisseria meningitidis. Epidemiol. Infect. 133:883-889. http://dx.doi.org/10.1017/S0950268805004097.
44. Robinson K, Neal KR, Howard C, Stockton J, Atkinson K, Scarth E, Moran J, Robins A, Todd I, Kaczmarski E, Gray S, Muscat I, Slack R, Ala'Aldeen DA. 2002. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect. Immun. 70:1301-1309. http://dx.doi.org/10.1128/IAI.70.3.1301-1309.2002.
45. Weynants VE, Feron CM, Goraj KK, Bos MP, Denoel PA, Verlant VG, Tommassen J, Peak IR, Judd RC, Jennings MP, Poolman JT. 2007. Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis. Infect. Immun. 75:5434-5442. http://dx.doi.org/10.1128/IAI.00411-07.
46. Corthesy B. 2013. Multifacted functions of secretory IgA at mucosal surfaces. Front. Immunol. 4:1-11. http://dx.doi.org/10.3389/fimmu.2013.00185.
47. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, Donnelly JJ, Berti F, Savino S, Scarselli M, Costantino P, Kroll JS, O'Dwyer C, Qiu J, Plaut AG, Moxon R, Rappuoli R, Pizza M, Arico B. 2010. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc. Natl. Acad. Sci. U. S. A. 107:3770-3775. http://dx.doi.org/10.1073/pnas.0915162107.
48. Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R. 2013. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect. Dis. 13:416-425. http://dx.doi.org/10.1016/S1473-3099(13) 70006-9.
49. Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM, Maiden MC. 2004. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 72:5955-5962. http://dx.doi.org/10.1128/IAI.72.10.5955-5962.2004.